Colin Coros is an experienced executive specializing in life sciences and health technologies. As the former CEO of the Delta Genomics Centre, Dr. Coros built a national diagnostics company for the livestock industry. He is also the co-founder of Helios Genomics, a metagenomics company specializing in the Energy sector. Colin earned a PhD in Biochemistry from the University of Western Ontario, an MBA from the Edward School of Business at the University of Saskatchewan in Saskatoon, Saskatchewan, and completed Postdoctoral Fellowships at the Wadsworth Centre in Albany, New York, and the University of Calgary in Calgary, Alberta.
Current role
Chief Commercialization Officer at TerViva
EVP & Chief Commercialization Officer at IACMI
Chief Commercialization Officer at OsteoCentric Technologies
Chief Commercialization Officer at Biofourmis
EVP & Chief Commercialization Officer at Bristol-Myers Squibb
Access the worlds's biggest network of public org charts
Learn more